<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">
 <italic>Cimicifuga racemosa</italic> (L.) Nutt., 
 <italic>Melia azedarach</italic> L., 
 <italic>Coptis chinensis</italic> Franch., 
 <italic>Phellodendron chinense</italic> C.K.Schneid., and 
 <italic>Sophora tonkinensis</italic> var. 
 <italic>polyphylla</italic> X.C.Huang &amp; Z.C.Zhou decreased mouse hepatitis virus A59 (MHV-A59) production and intracellular viral RNA and protein expression with EC
 <sub>50</sub> values ranging from 2 to 27.5 μg/ml (Kim et al. 
 <xref ref-type="bibr" rid="CR53">2008</xref>). 
 <italic>Cimicifuga racemosa</italic>, 
 <italic>M. azedarach</italic>, 
 <italic>C. chinensis</italic>, 
 <italic>P. chinense</italic>, and 
 <italic>S. tonkinensis</italic> were good candidates for the treatment of coronaviral infections in both humans and animals (Kim et al. 
 <xref ref-type="bibr" rid="CR53">2008</xref>). The underlying antiviral mechanism was most likely due to the inhibition of RNA-dependent RNA polymerase or proteases that are crucial for coronavirus RNA replication. 
 <italic>Melia azedarach</italic> and 
 <italic>C. chinensis</italic> may also affect virus assembly or release.
</p>
